SCHEMBL10709628

SCHEMBL10709628

COc1cc2c(cc1[S+]([O-])c1ccccc1)CCN(C)CC2

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 6/20 0.54
▸ DRD5 P21918 6/20 0.54
▸ DRD4 P21917 3/20 0.54
▸ DRD2 P14416 4/20 0.49
▸ DRD3 P35462 4/20 0.49
▸ MAOA P21397 2/20 0.49
▸ MAOB P27338 2/20 0.49
▸ SLC6A4 P31645 1/20 0.49
▸ CHRNA7 P36544 2/20 0.48
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10701316 0.83 HTR2C (0.48) DRD1DRD5
SCHEMBL10700207 0.81 DRD1 (0.51) DRD1DRD5DRD4DRD2DRD3
SCHEMBL10703630 0.81 ESR1 (0.48) KDM4EALOX15HSD17B10
SCHEMBL11158095 0.78 DRD1 (0.45) DRD1DRD5DRD4DRD2DRD3
SCHEMBL11169272 0.73 MAOA (0.84) DRD1DRD5DRD4DRD2DRD3
Hydrochloric Acid SCHEMBL11158000 0.71 MAOA (0.81) DRD1DRD5DRD4DRD2DRD3
SCHEMBL6915522 0.70 CA1 (0.46) CYP3A4KDM4EALOX15HSD17B10
SCHEMBL10747934 0.70 CYP2D6 (0.74) DRD1DRD5DRD2SLC6A4CYP3A4
SCHEMBL11582017 0.69 MAOB (0.46) MAOBCYP3A4KDM4EHSD17B10
SCHEMBL440865 0.69 CA12 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0285287-A2 3-Benzazepine compounds for use in treating gastrointestinal motility disorders SMITHKLINE BEECHAM CORPORATION (US) 1988-10-05 — — EP disclosed
Send feedback